Nephros (NEPH) Accumulated Depreciation & Amortization (2016 - 2025)
Nephros (NEPH) has 14 years of Accumulated Depreciation & Amortization data on record, last reported at $1.0 million in Q4 2024.
- For Q4 2024, Accumulated Depreciation & Amortization rose 4.89% year-over-year to $1.0 million; the TTM value through Dec 2024 reached $1.0 million, up 4.89%, while the annual FY2024 figure was $1.0 million, 4.89% up from the prior year.
- Accumulated Depreciation & Amortization reached $1.0 million in Q4 2024 per NEPH's latest filing, up from $962000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $1.0 million in Q4 2024 and bottomed at $829000.0 in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $913200.0, with a median of $923000.0 recorded in 2022.
- Peak YoY movement for Accumulated Depreciation & Amortization: fell 1.66% in 2021, then increased 11.34% in 2022.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $843000.0 in 2020, then dropped by 1.66% to $829000.0 in 2021, then rose by 11.34% to $923000.0 in 2022, then grew by 4.23% to $962000.0 in 2023, then increased by 4.89% to $1.0 million in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $1.0 million in Q4 2024, $962000.0 in Q4 2023, and $923000.0 in Q4 2022.